Free communications on HPV and Head & Neck cancer 1

• HN 03-01 • Prevalence of human papillomavirus in tonsillar/adenoid tissue. A study of paraffin-embedded archival material from diagnostic biobanks in Norway See abstract > M. Mona HANSEN • HN 03-02 • Time to change perspectives on HPV in oropharyngeal cancer - A systematic review of HPV prevalence per oropharyngeal sub-site See abstract > L. Linnea HAEGGBLOM • HN 03-03 • Increasing prevalence of HPV-positive tumor status among older adults with oropharyngeal cancer, 1995- 2013 See abstract > M. Melina BENSON • HN 03-04 • HPV 16 and EPB41L3 methylation: concordance between measures in oropharyngeal (OPC) tumor and oral gargle specimens and case control differences See abstract > A. Anna GIULIANO • HN 03-05 • P16INK4A expression patterns predict clinical outcome of patients with oral dysplasia irrespective of HPV infection status See abstract > M. Miriam ROSIN • HN 03-06 • High-risk human papillomaviruses and p16 in oral cancer See abstract > A. Anak IAMAROON • HN 03-07 • Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3 See abstract > C. Cinzia BERSANI • HN 03-08 • Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011-2014 See abstract > A-L. Amanda-Louise CARLANDER • HN 03-09 • Efficacy of AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in adolescent girls - results from a community-randomized trial See abstract > F. Frank STRUYF • HN 03-10 • Four-parameter model for predicting outcome in patients with HPV-positive tonsillar and base of tongue squamous cell carcinoma See abstract > M. Michael MINTS